# Safety, Blood Levels and Effects of AUT00206

> **NCT02589262** · PHASE1 · COMPLETED · sponsor: **Autifony Therapeutics Limited**

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** AUT00206

## Key facts

- **NCT ID:** NCT02589262
- **Lead sponsor:** Autifony Therapeutics Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** — (—)
- **Last updated:** 2016-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02589262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02589262, "Safety, Blood Levels and Effects of AUT00206". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02589262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*